Haemoglobin adducts of N-nitroso compounds

European Journal of Cancer Prevention

Volumn 5, Issue SUPPL. 1, 1996, Pages 115-119

  Richter, E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN ADDUCT; NITROSO DERIVATIVE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; HUMAN; MONITORING; NITROSATION; PRIORITY JOURNAL; TOBACCO;

ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA ADDUCTS; DNA DAMAGE; HEMOGLOBINS; HUMANS; NEOPLASMS; NITROSO COMPOUNDS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 0030470051     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199609001-00024     Document Type: Conference Paper

References (32)

1. Bailey E, Brooks AGF, Dollery CT et al (1988). Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake. Arch Toxicol 62: 247-53.
2. Bailey E, Farmer PB, Tang Y-S et al (1991). Hydroxyethylation of hemoglobin by 1-(2-chloroethyl)-1-nitro-soureas. Chem Res Toxicol 4: 462-6.
3. Bryant MS, Skipper PL, Tannenbaum SR et al (1987). Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47: 602-8.
4. Bryant MS, Vineis P, Skipper PL et al (1988). Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci USA 85: 9788-91.
5. Carmella SG, Hecht SS (1987). Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Cancer Res 47: 2626-30.
6. Carmella SG, Kagan SS, Kagan M et al (1990). Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff-dippers, smokers and non-smokers. Cancer Res 50: 5438-45.
7. Carmella SG, Akerkar S, Hecht SS (1993). Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1(3-pyridyl)- 1-butanone in smokers' urine. Cancer Res 53: 721-4.
8. Charest M, Rossignol G, Castonguay A (1989). In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues. Chem Biol Interact 71: 265-78.
9. Ehrenberg L, Hiesche KD, Osterman-Golkar S et al (1974). Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24: 83-103.
10. Falter B, Kutzer C, Richter E (1994). Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin Invest 72: 364-71.
11. Farmer PB, Shuker DEG, Bird I (1986). DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 7: 49-52.
12. Hecht SS (1994). Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab Rev 26: 373-90.
13. Hecht SS, Carmella SG, Murphy SE et al (1993). A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med 329: 1543-6.
14. Hoffmann D, Brunnemann KD, Prokopczyk B et al (1994). Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity and relevance to humans. J Toxicol Envir Hlth 41: 1-52.
15. Hong J-Y, Ding X, Smith TJ et al (1992). Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb. Carcinogenesis 13: 2141-4.
16. Kim S, Paik WK, Choi J et al (1981). Microsome-dependent methylation of erythrocyte proteins by dimethylnitrosamine. Carcinogenesis 2: 179-82.
17. Kutzer C, Richter E, Oehlmann C et al (1995). Effect of nicotine and cotinine on NNK metabolism in rats. In Effects of Nicotine on Biological Systems II (eds Clarke PBS, Quik M, Adlkofer F et al); Birkhäuser Verlag, Basel, pp. 385-90.
18. Murphy SE, Heiblum R (1990). Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N′-nitrosonornicotine and 4-methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue. Carcinogenesis 11: 1663-6.
19. Murphy SE, Palomino A, Hecht SS et al (1990). Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 50: 5446-52.
20. Murphy SE, Coletta KA (1993). Two types of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells. Cancer Res 53: 777-83.
21. Murphy SE, Carmella SG, Idris AM et al (1994). Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol Biomarkers Prev 3: 423-8.
22. Osterman-Golkar S, Bergmark E (1988). Alkylation of haemoglobin, plasma proteins and DNA in the mouse by diethylnitrosamine. Carcinogenesis 9: 49-52.
23. Osterman-Golkar S, Ehrenberg L, Segerbäck D et al (1976). Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res 34: 1-10.
24. Pereira MA, Chang LW (1981). Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem Biol Interact 33: 301-5.
25. Peterson LA, Carmella SG, Hecht SS (1990). Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 11: 1329-33.
26. Richter E, Falter B, Scherer G et al (1994). Regional differences in hemoglobin adducts from aromatic amines. Can J Physiol Pharmacol 72 (Suppl 1): P22.2.32.
27. Richter E, Tricker AR (1994). Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis 15: 1061-4.
28. Richter E, Branner B, Kutzer C et al (1995). Comparison of biomarkers for exposure to environmental tobacco smoke: cotinine and haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and nonsmoking women. In Proc Healthy Buildings '95, Volume 2 (ed Maroni M); University of Milano, pp. 599-605.
29. Schuller HM, Castonguay A, Orloff M et al (1991). Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine in hamster lung. Cancer Res 51: 2009-14.
30. Skipper PL, Tannenbaum SR (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11: 507-18.
31. Törnqvist M, Osterman-Golkar S, Kautiainen A et al (1986). Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7: 1519-21.
32. Törnqvist M, Osterman-Golkar S, Kautiainen A et al (1988). Methylations in human hemoglobin. Mutat Res 204: 521-9.